42
total announcements
KRSNAA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 16 Oct 2026
Market Cap
₹1,816 Cr
P/E (TTM)
18.0
P/E (Forward)
11.5
EPS (TTM)
₹29.65
52W Low
₹515.00
52W High
₹843.35
Dividend Yield
0.38%
Beta
0.01
Price / Book
1.8
Debt / Equity
54.5
Revenue (TTM)
₹841 Cr
Gross Margin
78.39%
Operating Margin
12.75%
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has clarified an earlier announcement regarding the allotment of fully convertible warrants on a preferential basis, correcting a typographical error in the premium amount.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has allotted 16,21,000 fully convertible warrants to promoters and promoter group entities at ₹566 per warrant, with an option to convert into equity shares within 18 months.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has received an in-principle approval from BSE Limited for the issue of 16,21,000 convertible warrants on a preferential basis to the promoter and promoter group.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has received in-principle approval from BSE and NSE for the issue of 16,21,000 convertible warrants on a preferential basis to the promoter and promoter group.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has received in-principle approval from BSE and NSE for the issue of 16,21,000 convertible warrants on a preferential basis to the promoter and promoter group. The warrants are convertible into 16,21,000 equity shares at an issue price of Rs. 566 each.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, regarding dematerialization and rematerialization of securities.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has submitted revised voting results for its 16th Annual General Meeting, correcting an error in the voting process. The company declared a final dividend of INR 2.00 per equity share and re-appointed Mr. Yash Mutha as a director.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about the appointment of M/s Kirtane & Pandit LLP as the Statutory Auditor of the Company for a first term of 5 consecutive years.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has submitted the Exchange a copy of the Scrutinizers report of the Annual General Meeting held on September 28, 2026, and informed the Exchange regarding voting results.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about General Updates, specifically the sale of identified diagnostic equipment for up to ₹120 crore to identified purchaser(s) as part of its strategic initiative to optimise its asset portfolio and enhance capital efficiency.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026. The meeting commenced at 11:00 Hrs. (IST) and concluded at 12:10 Hrs. (IST). A total of 36 Members attended the AGM in person / through authorised representatives.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has closed its trading window for insiders due to the declaration of unaudited financial results for the quarter and half year ending September 30, 2026.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot and informed the Exchange regarding voting results. The company has passed a special resolution to issue up to 16,21,000 warrants convertible into equity shares on a preferential basis to the promoter and promoter group.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has entered the PET-CT diagnostic services segment through a Public Private Partnership (PPP) model with the Department of Health & Family Welfare, Government of Punjab, for the development, operation, and maintenance of PET-CT Diagnostic Facilities at 4 government hospitals in Punjab. The project is a 15-year concession agreement with a cash-based revenue model, providing long-term revenue visibility.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about General Updates, specifically regarding the dispatch of Annual Report for FY 2025-26 and notice of 16th Annual General Meeting (AGM) to shareholders.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has received appellate orders from the Commissioner of Income Tax (Appeals), Pune, in relation to income-tax proceedings for Assessment Years 2017-18 to 2023-24. The company has disputed demands totaling ₹62,69,17,435, which are subject to further appellate proceedings.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about the completion of the dispatch of Annual Report and the Notice Convening the 16th Annual General Meeting of the Company.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026, along with the Annual Report for the Financial Year 2025-26.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has informed the Exchange about the publication of notice of the 16th Annual General Meeting of the Company, scheduled on September 28, 2026.
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has submitted a copy of newspaper publication regarding a corrigendum to the notice of postal ballot for a preferential issue of warrants.